Learn about an FDA-approved treatment for cataplexy and/or excessive daytime sleepiness in narcolepsy and for idiopathic hypersomnia (IH) in adults. See full Prescribing Information & …

Xywav is used for the treatment of cataplexy and excessive daytime sleepiness (EDS) in patients with narcolepsy, and idiopathic hypersomnia (IH). Includes Xywav side effects, interactions …

The safety and effectiveness of XYWAV for the treatment of cataplexy or excessive daytime sleepiness in pediatric patients 7 years of age and older with narcolepsy have been established.

Xywav was originally FDA-approved in 2002 to treat excessive daytime sleepiness (EDS) and cataplexy (sudden muscle weakness triggered by strong emotions) in people at least 7 years …

Xywav is also approved to treat excessive daytime sleepiness and cataplexy (sudden muscle weakness) related to narcolepsy. Side effects of Xywav when used to treat these narcolepsy …

Treatment for hypersomnia -- excessive daytime sleepiness -- depends on the cause of the sleep disorder. For example, if you are diagnosed with sleep apnea, your doctor may prescribe a …

Excessive daytime sleepiness Sleep inertia Severe grogginess or confusion when waking up regardless of how much sleep you get or how many alarms you set—feeling disoriented, …

Xywav, also known as JZP258, is a lower-sodium oxybate treatment taken at night to help treat multiple symptoms of IH, including excessive daytime sleepiness, sleep inertia, long sleep time …

Xywav is the first FDA approved new treatment option indicated for both cataplexy and excessive daytime sleepiness in people living with narcolepsy in more than 15 years Xywav contains 92 …

Could XYWAV be right for your adult patients with Idiopathic Hypersomnia (IH)? XYWAV is the only FDA-approved treatment for IH. 1,2 Consider XYWAV—a treatment taken each night to …